NMVA
BLPH
New Mountain Vantage Advisers’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-252,650
| Closed | -$1.31M | – | 10 |
|
|
2021
Q1 | $1.31M | Sell |
252,650
-756,581
| -75% | -$3.93M | 0.03% | 11 |
|
|
2020
Q4 | $6.73M | Hold |
1,009,231
| – | – | 0.78% | 3 |
|
|
2020
Q3 | $10.3M | Hold |
1,009,231
| – | – | 0.53% | 12 |
|
|
2020
Q2 | $12.7M | Buy |
1,009,231
+909,000
| +907% | +$11.4M | 0.6% | 14 |
|
|
2020
Q1 | $16.9M | Sell |
100,231
-15,038,255
| -99% | -$2.54B | 0.91% | 10 |
|
|
2019
Q4 | $7.34M | Hold |
15,138,486
| – | – | 0.28% | 22 |
|
|
2019
Q3 | $7.3M | Hold |
15,138,486
| – | – | 0.29% | 26 |
|
|
2019
Q2 | $13.5M | Hold |
15,138,486
| – | – | 0.47% | 25 |
|
|
2019
Q1 | $14.4M | Hold |
15,138,486
| – | – | 1.68% | 22 |
|
|
2018
Q4 | $17M | Hold |
15,138,486
| – | – | 1.88% | 22 |
|
|
2018
Q3 | $16.4M | Hold |
15,138,486
| – | – | 1.18% | 27 |
|
|
2018
Q2 | $36.6M | Hold |
15,138,486
| – | – | 2.82% | 18 |
|
|
2018
Q1 | $31.5M | Hold |
15,138,486
| – | – | 2.58% | 21 |
|
|
2017
Q4 | $37.2M | Hold |
15,138,486
| – | – | 2.82% | 17 |
|
|
2017
Q3 | $20.1M | Buy |
15,138,486
+4,564,315
| +43% | +$6.05M | 1.54% | 30 |
|
|
2017
Q2 | $14.2M | Hold |
10,574,171
| – | – | 1.03% | 38 |
|
|
2017
Q1 | $15.8M | Hold |
10,574,171
| – | – | 1.1% | 37 |
|
|
2016
Q4 | $5.5M | Buy |
10,574,171
+5,714,286
| +118% | +$2.97M | 0.35% | 39 |
|
|
2016
Q3 | $6.8M | Hold |
4,859,885
| – | – | 0.4% | 33 |
|
|
2016
Q2 | $8.6M | Hold |
4,859,885
| – | – | 0.45% | 36 |
|
|
2016
Q1 | $12M | Hold |
4,859,885
| – | – | 0.64% | 31 |
|
|
2015
Q4 | $14.4M | Hold |
4,859,885
| – | – | 0.67% | 35 |
|
|
2015
Q3 | $25.2M | Buy |
+4,859,885
| New | +$25.2M | 0.98% | 32 |
|